Future of Cancer care is bright !! ⁦CCF Hematology Oncology Fellows⁩ ⁦Cleveland Clinic MD⁩ ⁦Cleveland Clinic⁩ !

Happy Friday. Tie up loose ends today so you enjoy a slow weekend. Read a book you love. Life is good. ☕️📚👍🏽

FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer. fda.gov/drugs/resource… #OCENewsBurst

☕️📚💊 This is a timely, comprehensive review of colorectal cancer — just published in The Lancet. 💊SOC treatment (especially as pt pop’n increasingly startified by genotype) 💊Key trials 💊Emerging trends Timely as we head into ESMO GI next week. bit.ly/4bepZLU

☕️📚☀️ Summer is a great time to get a few meaningful books in. The ⁦Financial Times⁩ compiles an excellent list each year across disciplines (including recs from their journalists): 📚History (my favorite) 📚Business / Economics 📚Arts / Fashion on.ft.com/4berSIj

☕️📚💊 Finally had time to listen to “Acquired” — a podcast that delves deep into corporate histories over 3-4 hour episodes. This history of ⁦Novo Nordisk⁩ is fascinating — from 2 rival companies to one of the largest (pharma) companies today. podcasts.apple.com/us/podcast/acq…

☕️☀️📚Recently flew back to Chicago & captured this video. Beautiful city.

Bloomberg Philanthropies gives $1B to Johns Hopkins University. This gift makes the School of Medicine tuition-free for students from families earning under $300,000, and students from families earning up to $175,000 will receive a full ride, including living expenses.

Welcome to our new Chief Fellow, Dr. Alexandra Rojek!! We know she will do great things this year and are thrilled for her to be in this leadership role! Congratulations, Dr. Rojek! University of Chicago Hem/Onc Fellows

We are thrilled to welcome our newest class of first year fellows to University of Chicago Hematology/Oncology and excited to see you begin on your path to becoming oncologists! And a huge thank you to Olufunmilayo Olopade for hosting our tradition of the new fellows' reception on a beautiful summer evening!

Tornado warning in Chicagoland tonight. Stay safe everyone. Seek shelter if you’re in affected areas. Be sure to take provisions (food, water) and a flashlight. We’re in the basement with the kids — waiting this out.

☕️📚💊 These were the 4 most influential textbooks of my oncology fellowship — which I chose to focus on novel therapeutics. It will prepare one well for both industry & academic careers focused on translating novel biology, targets & therapeutics to patients.

I'm saddened by the news of the passing of Charis Eng, MD, PhD. She was a brilliant scientist and strong mentor who dedicated her life to scientific research. I'm proud to have completed my thesis research under her tutelage. This is a great loss. Rest in peace, Dr. Eng.

☕️💊📚 Book #15 of the year (goal: 24): Dr Ahmed practiced as a physician-scientist-oncologist at MD Anderson before joining AstraZeneca in clinical development. This is both primer & history lesson on drug development. Worth a read if you want a balanced industry-academia view

☕️📚☀️ Happy Friday. This summer went by fast — but it’s not over yet. Enjoy the remaining few weeks. Life is good.

This week, one of the deans of germline cancer genetics Charis Eng, MD, PhD passed away. She was the force behind research on the cancer predisposition syndrome PTEN Hamartoma Tumor Syndrome (PHTS), co-discovering the presence of germline PTEN mutations in individuals with Cowden

☕️📚💊Kicking off my first “real” job after 10 yrs of medical training by re-reading one of my favorite books on drug development. The story of how industry & academia jointly developed imatinib (Gleevec) — the 1st approved targeted therapy (BCR-ABL1/c-KIT/PDGFRA) in oncology.

CEO of Abbott writes about the decision to scrap & entirely re-design a flagship product that was expensive & hard to use for patients. He walks us through the tough decision & the complex process of coordinating R&D expertise & commercial resources. hbr.org/2024/09/the-ce…